The purpose of this two-day congress is to foster interactions between pharmaceutical industries, research labs, service providers, technology developers, and clinicians, thereby contributing to the development of innovative strategies against infectious diseases in a multidisciplinary approach.
For this year edition, the congress will address the thematic of Emerging diseases and antimicrobial-resistance.
The I4ID2022 will include keynote lectures, pitch talks of new innovative projects, industrial talks from pharmaceutical companies and poster presentations.
Register to the event and book a meeting on i4id.org
The team will be pleased to welcome you on our booth 21 or during the B2B meetings to learn more on our brand new state-of-the-art facility and how our models, expertise and know-how in infectious and respiratory diseases could speed up the development of your candidates.
A great opportunity to showcase and discuss our last efficacy model with our poster entitled “Preclinical efficacy, safety and immunogenicity assessment of a vaccine candidate in a NHP model of SARS-CoV-2 infection”.
